Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
https://www.alvarezandmarsal.com/insights/is-omicron-our-way-out
In Part 2 of our podcast series on nursing shortages in the US, we sit down with three Chief Nursing Officers to learn where...
Leveraging contingent staff in her workforce was not only a pandemic necessity but an ongoing part of the workforce strategy that Dr. Laura Canfield,...
In Part II of The Impact of COVID-19 on Cybersecurity Across the Healthcare Industry, A&M Managing Directors, Ken Barrette and Rocco Grillo, and Senior...
